BIOFREEDOM Stent Versus ORSIRO Stent: SORT OUT IX

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 3150 participants.

Also called NCT02623140

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 3,150 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02623140
Other papers using this trial's data
  • Randomized Comparison of the Polymer-Free Biolimus-Coated BioFreedom Stent With the Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Orsiro Stent in an All-Comers Population Treated With Percutaneous Coronary Intervention: The SORT OUT IX Trial Circulation, 2020-06-23 DOI, PubMed 32434381

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Denmark (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02623140. Randomized; single masking; primary purpose treatment. Start 2015-12 (registry gives no type); primary completion 2018-10-01 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
BIOFREEDOM Stent Versus ORSIRO Stent: SORT OUT IX
Acronym
SORT OUT IX
Condition
Ischaemic Heart Disease
Intervention (Device)
Biofreedom
Intervention (Device)
Orsiro
Lead sponsor
Odense University Hospital (class: other)
Collaborator
Aarhus University Hospital Skejby (class: other)
Collaborator
Aalborg University Hospital (class: other)
Collaborator
Copenhagen University Hospital, Rigshospitalet (class: other)

Record details

Record id
cardio:ct-nct02623140
Content hash
dc2bdd0e9e2d2e4850e9a9c170322a0f833207653c0d78a9d8db3156dc08574b